C81.97
Hodgkin lymphoma, unspecified, spleen
Clinical Classification Guidelines
Medical Intelligence & Overview
Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, which is part of the body's immune defense. When this disease involves the spleen, which plays a key role in filtering blood and supporting immune functions, it is classified under the ICD-10 code C81.97. This condition can affect how the spleen functions and may involve other areas of lymphatic tissue in the body. Recognizing the signs and understanding the basics about this disease can be vital for early detection and management.
Causes & Symptoms
Clinical Causes: Genetic factors may predispose individuals to Hodgkin lymphoma. Infection with Epstein-Barr Virus (EBV) has been associated with the disease. Compromised immune system conditions, such as HIV/AIDS or immunosuppressive therapy, can increase risk. Family history of lymphoma or other blood cancers might elevate susceptibility. Exposure to certain chemicals or toxins has been suggested as potential risk factors.
Key Symptoms: Swelling or painless enlargement of lymph nodes, especially in the neck, armpits, or groin. Unexplained weight loss separated over a short period. Persistent fever without an obvious infection. Night sweats, often severe and soaking. Fatigue or a general feeling of tiredness. Itching skin, sometimes widespread. Pain or discomfort in the area of the spleen, which may be felt in the upper left abdomen.
Diagnostic & Treatment
Diagnosis Path: Medical history review and physical examination focusing on lymph nodes and spleen. Imaging tests such as CT scans, PET scans, or ultrasound to visualize lymphatic tissue and the spleen. Blood tests to evaluate overall health, detect abnormal blood counts, and assess organ function. Lymph node or spleen biopsy to confirm the presence of Hodgkin Reed-Sternberg cells, characteristic of Hodgkin lymphoma. Additional tests to determine the extent of the disease and whether it has spread to other areas.
Treatment Protocols: Chemotherapy: Use of drugs to kill cancer cells, often the main treatment modality. Radiation therapy: Targeted radiation may be used to eliminate localized cancer areas. Immunotherapy: Employing agents that help the immune system recognize and attack cancer cells. Stem cell transplant: For advanced or relapsed cases, high-dose chemotherapy followed by stem cell transplant may be considered. Surgical removal of the spleen (splenectomy): In certain cases, especially if the spleen is significantly affected or causing symptoms, removal may be necessary. Supportive care: Managing symptoms and side effects during treatment, including infection prevention strategies given the spleen's role in immune function.
Clinical Advice & FAQs
Billing Guidance
Is C81.97 a billable ICD-10 code?
Yes, C81.97 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.97?
Clinical documentation must specify the nature of Hodgkin lymphoma, unspecified, spleen and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
